Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in ...

Executives at the Minnesota-run medtech giant have banked on the high blood pressure-curbing renal denervation system to ...

The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...

Hims & Hers Health HIMS-3.85%decrease; red down pointing triangle said it is now providing menopause care, marking the company’s latest push into hormone-replacement therapies. The telehealth company ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — The German biotech Tubulis, which is designing a series of ...

Every few weeks, a 65-year-old man named Rick drives an hour and a half from his home in New Hampshire to Brigham and Women’s Hospital in Boston, where a nurse inserts a needle in his arm and a clear ...

Millions of adults in their 20s or older have coronary artery disease. But experts say the common condition doesn’t have to be an inevitable part of aging. There are steps you can take to reduce your ...

You might be surprised to find out that liver disease isn’t only caused by heavy drinking. In fact, an increasing number of people are being diagnosed with liver disease from a much more common cause, ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring and breathing difficulties. The approval marks the ...